Midodrine Hcl

Product manufactured by Cardinal Health

Application Nr Approved Date Route Status External Links
ANDA076725 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Midodrine Hydrochloride Tablets Are Indicated For The Treatment Of Symptomatic Orthostatic Hypotension (oh). Because Midodrine Hydrochloride Tablets Can Cause Marked Elevation Of Supine Blood Pressure (bp>200 Mmhg Systolic), It Should Be Used In Patients Whose Lives Are Considerably Impaired Despite Standard Clinical Care, Including Non-Pharmacologic Treatment (such As Support Stockings), Fluid Expansion, And Lifestyle Alterations. The Indication Is Based On Midodrine's Effect On Increases In 1-Minute Standing Systolic Blood Pressure, A Surrogate Marker Considered Likely To Correspond To A Clinical Benefit. At Present, However, Clinical Benefits Of Midodrine Hydrochloride Tablets, Principally Improved Ability To Perform Life Activities, Have Not Been Established. Further Clinical Trials Are Underway To Verify And Describe The Clinical Benefits Of Midodrine. After Initiation Of Treatment, Midodrine Hydrochloride Tablets Should Be Continued Only For Patients Who Report Significant Symptomatic Improvement.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Midodrine Hydrochloride MIDODRINE HYDROCHLORIDE ZINC507

Comments